Vitamin D status in pregnancy and cord blood is associated with symptoms of attention-deficit hyperactivity disorder at age 5 years: Results from Odense Child Cohort

被引:0
|
作者
Thinggaard, Camilla Munk [1 ,2 ,3 ]
Dalgard, Christine [4 ]
Moller, Soren [5 ,6 ]
Christesen, Henrik Boye Thybo [2 ,7 ]
Bilenberg, Niels [1 ,2 ]
机构
[1] Reg Southern Denmark, Dept Child & Adolescent Psychiat, Mental Hlth Hosp & Univ Clin, JP Winsloews Vej 28, DK-5000 Odense C, Denmark
[2] Univ Southern Denmark, Fac Hlth Sci, Dept Clin Res, Odense, Denmark
[3] Aalborg Univ Hosp, Acute & Med Dept, Thisted, Denmark
[4] Univ Southern Denmark, Dept Publ Hlth Clin Pharmacol Pharm & Environm Med, Odense, Denmark
[5] Univ Southern Denmark, Dept Clin Res, Res Unit OPEN, Odense, Denmark
[6] Odense Univ Hosp, OPEN Open Patient Data Explorat Network, Odense, Denmark
[7] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Odense, Denmark
来源
关键词
Attention-deficit hyperactivity disorder; vitamin D; prenatal; neurodevelopment; CBCL/11/2-5; cohort study;
D O I
10.1177/00048674241272018
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Vitamin D status in pregnancy may affect offspring neurodevelopment. Objective: The objective was to investigate the association between serum 25-hydroxyvitamin D in cord blood and pregnancy and symptoms of attention-deficit hyperactivity disorder in 5-year-old offspring. Method: In Odense Child Cohort, Denmark, 944 mother-child pairs had data on pregnancy or cord serum 25-hydroxyvitamin D and parent-rated attention-deficit hyperactivity disorder symptom score by Child Behavior Checklist for ages 1.5-5 years. Adjusted multiple linear regression and two-stage exposure analyses were performed for serum 25-hydroxyvitamin D associations to the attention-deficit hyperactivity disorder symptom score. Results: The mean (standard deviation) serum 25-hydroxyvitamin D in cord blood was 48.0 (21.8) nmol/L; early pregnancy was 65.5 (20.2) nmol/L and late pregnancy was 79.3 (25.7) nmol/L. The median (interquartile range) age of child at examination was 5.2 (5.1-5.4) years and median (interquartile range) attention-deficit hyperactivity disorder symptom score was 2 (0-3) points. In adjusted analyses, serum 25-hydroxyvitamin D of <25 nmol/L and <32 nmol/L in cord blood and <25 nmol/L in early pregnancy was associated with 0.9 [95% confidence interval: 0.4, 1.3], 0.5 [0.1, 0.9] and 2.1 [0.8, 3.4] points higher attention-deficit hyperactivity disorder symptom score vs reference. In the two-stage exposure analysis, attention-deficit hyperactivity disorder symptom score decreased by 0.4 points per 25 nmol/L increase in serum 25-hydroxyvitamin D. Moreover, serum 25-hydroxyvitamin D of <25 nmol/L in early pregnancy and cord was associated with a five-fold and a two-fold risk of attention-deficit hyperactivity disorder symptom score >= 90th percentile, adjusted odds ratio [95% confidence interval] = 4.9 [1.3, 19.0] and 2.2 [1.2, 3.9]. Conclusion: In this cohort, serum 25-hydroxyvitamin D <25 nmol/L in cord blood and early pregnancy were risk factors for higher attention-deficit hyperactivity disorder symptom score in 5-year-old children, suggesting a protective effect of vitamin D on attention-deficit hyperactivity disorder traits at preschool age.
引用
收藏
页码:1090 / 1102
页数:13
相关论文
共 50 条
  • [41] Maternal and cord plasma branched-chain amino acids and child risk of attention-deficit hyperactivity disorder: a prospective birth cohort study
    Anand, Neha S.
    Ji, Yuelong
    Wang, Guoying
    Hong, Xiumei
    van der Rijn, Madeleine
    Riley, Anne
    Pearson, Colleen
    Zuckerman, Barry
    Wang, Xiaobin
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2021, 62 (07) : 868 - 875
  • [42] Maternal depressive symptoms during and after pregnancy are associated with attention-deficit/hyperactivity disorder symptoms in their 3-to 6-year-old children
    Wolford, Elina
    Lahti, Marius
    Tuovinen, Soile
    Lahti, Jari
    Lipsanen, Jari
    Savolainen, Katri
    Heinonen, Kati
    Hamalainen, Esa
    Kajantie, Eero
    Pesonen, Anu-Katriina
    Villa, Pia M.
    Laivuori, Hannele
    Reynolds, Rebecca M.
    Raikkonen, Katri
    PLOS ONE, 2017, 12 (12):
  • [43] Blood Levels of Trace Elements in Children with Attention-Deficit Hyperactivity Disorder: Results from a Case-Control Study
    Rongwang Yang
    Yanyi Zhang
    Weijia Gao
    Nannan Lin
    Rong Li
    Zhengyan Zhao
    Biological Trace Element Research, 2019, 187 : 376 - 382
  • [44] Blood Levels of Trace Elements in Children with Attention-Deficit Hyperactivity Disorder: Results from a Case-Control Study
    Yang, Rongwang
    Zhang, Yanyi
    Gao, Weijia
    Lin, Nannan
    Li, Rong
    Zhao, Zhengyan
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2019, 187 (02) : 376 - 382
  • [45] Attention-deficit/hyperactivity disorder symptoms in adults with self-reported epilepsy: Results from a national epidemiologic survey of epilepsy
    Ettinger, Alan B.
    Ottman, Ruth
    Lipton, Richard B.
    Cramer, Joyce A.
    Fanning, Kristina M.
    Reed, Michael L.
    EPILEPSIA, 2015, 56 (02) : 218 - 224
  • [46] Examining Motivational Pathways From Adult Attention-Deficit/Hyperactivity Disorder Symptoms to Cannabis Use: Results From a Prospective Study of Veterans
    Stevens, Angela K.
    Gunn, Rachel L.
    Jackson, Kristina M.
    Borsari, Brian
    Metrik, Jane
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2021, 35 (01) : 16 - 28
  • [47] Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort
    Lemelin, Maxim
    Boukhris, Takoua
    Zhao, Jin-Ping
    Sheehy, Odile
    Berard, Anick
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (03):
  • [48] Pregnancy or cord 25-hydroxyvitamin D is not associated with measures of body fat or adiposity in children from three months to three years of age. An Odense Child Cohort study
    Larsen, Sos Dragsbaek
    Christensen, Mathilde Egelund
    Dalgard, Christine
    Lykkedegn, Sine
    Andersen, Louise Bjorkholt
    Andersen, Marianne Skovsager
    Glintborg, Dorte
    Christesen, Henrik Thybo
    CLINICAL NUTRITION, 2020, 39 (06) : 1832 - 1839
  • [49] Maternal iron status during pregnancy and attention deficit/hyperactivity disorder symptoms in 7-year-old children: a prospective cohort study
    Andrés Díaz-López
    Josefa Canals-Sans
    Jordi Julvez
    Silvia Fernandez-Barrés
    Sabrina Llop
    Marisa Rebagliato
    Nerea Lertxundi
    Loreto Santa-Marina
    Mònica Guxens
    Jordi Sunyer
    Victoria Arija
    Scientific Reports, 12 (1)
  • [50] Maternal iron status during pregnancy and attention deficit/hyperactivity disorder symptoms in 7-year-old children: a prospective cohort study
    Diaz-Lopez, Andres
    Canals-Sans, Josefa
    Julvez, Jordi
    Fernandez-Barres, Silvia
    Llop, Sabrina
    Rebagliato, Marisa
    Lertxundi, Nerea
    Santa-Marina, Loreto
    Guxens, Monica
    Sunyer, Jordi
    Arija, Victoria
    SCIENTIFIC REPORTS, 2022, 12 (01):